QCM
CYTK icon

Quantinno Capital Management’s Cytokinetics CYTK Stock Holding History

Quantinno Capital Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.47M Buy
52,598
+2,161
+4% +$137K 0.01% 1309
2025
Q4 		$3.2M Buy
50,437
+22,000
+77% +$1.37M 0.01% 1192
2025
Q3 		$1.56M Buy
+28,437
New +$1.17M ﹤0.01% 1306

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Quantinno Capital Management's CYTK Position: Q1 2026 in Review

Quantinno Capital Management increased its Cytokinetics (CYTK) stake by 4.3% in Q1 2026, buying an estimated $137K and bringing the position to 52,598 shares worth $3.47M. The position accounts for 0.01% of the portfolio, ranked #1309.

Quantinno Capital Management first reported a position in CYTK in Q3 2025 and has held it in 3 quarters since. 439 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.

  • Quantinno Capital Management held 52,598 shares of Cytokinetics worth $3.47M as of Q1 2026.
  • Quantinno Capital Management bought 2,161 Cytokinetics shares in Q1 2026, an estimated $137K.
  • Cytokinetics made up 0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #1309 holding.
  • Quantinno Capital Management first reported a position in Cytokinetics in Q3 2025 and has held it in 3 quarters since.
  • 439 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.